[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

September 2022 | 207 pages | ID: GF7089355160EN
GMD Research

US$ 2,635.00 US$ 3,100.00 -15 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global single cell multiomics market will reach $14,369.5 million by 2031, growing by 18.6% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.

Highlighted with 89 tables and 109 figures, this 207-page report “Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • Instruments
  • Consumables
  • Software
Based on Omics Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • Single Cell Genomics (SCG)
  • Single Cell Transcriptomics (SCT)
  • Single Cell Proteomics (SCP)
  • Single Cell Metabolomics (SCM)
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • Clinical Research
    • Oncology
    • Cell Therapy
    • Immunology
    • Neurology
    • Cell Biology
    • Other Types of Clinical Research
  • Translation Research
  • Synthetic Biology
By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • Human Samples
    • Cancer Tissues
    • Stem Cells
    • Immune Cells
    • Brain Cells
    • Other Human Samples
  • Animal Samples
  • Microbial Samples
By Workflow, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • Single-Cell Isolation and Dispensing
    • Fluorescence-Activated Cell Sorting (FACS)
    • Microfluidics
    • Magnetic-Activated Cell Sorting (MACS)
    • Random Seeding
    • Manual Cell Picking
    • Laser Capture Microdissection
    • Other Technologies of Single-Cell Isolation and Dispensing
  • Single-Cell Analysis
    • Polymerase Chain Reaction
    • Next-Generation Sequencing
    • Mass Cytometry
    • Mass Spectrometry
    • Other Technologies of Single-Cell Analysis
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
  • Research and Academic Laboratories
  • Biopharmaceutical and Biotech Companies
  • Contract Research Organizations (CROs)
  • Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • North America (U.S., Canada, and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

10x Genomics, Inc.

1CellBio, Inc.

Becton, Dickinson and Company

Berkeley Lights, Inc.

BGI Genomics Co., Ltd.

Bio-Rad Laboratories, Inc.

Bio-Techne Corporation

BioTuring, Inc.

Danaher Corporation (Cytiva Life Sciences)

Dolomite Bio

Fluidigm Corporation

Fluxion Biosciences

Illimina, Inc

Mission Bio, Inc.

Namocell, Inc.

NanoString Technologies, Inc.

Parse Biosciences, Inc.

Proteona

Qiagen N.V.

RareCyte, Inc.

Scipio Biosciences SAS

Shilps Sciences

Takara Bio Inc. (Takara Holdings)

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Instruments
3.3 Consumables
3.4 Software

4 SEGMENTATION OF GLOBAL MARKET BY OMICS TYPE

4.1 Market Overview by Omics Type
4.2 Single Cell Genomics (SCG)
4.3 Single Cell Transcriptomics (SCT)
4.4 Single Cell Proteomics (SCP)
4.5 Single Cell Metabolomics (SCM)

5 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Clinical Research
  5.2.1 Oncology
  5.2.2 Cell Therapy
  5.2.3 Immunology
  5.2.4 Neurology
  5.2.5 Cell Biology
  5.2.6 Other Types of Clinical Research
5.3 Translation Research
5.4 Synthetic Biology

6 SEGMENTATION OF GLOBAL MARKET BY SAMPLE TYPE

6.1 Market Overview by Sample Type
6.2 Human Samples
  6.2.1 Cancer Tissues
  6.2.2 Stem Cells
  6.2.3 Immune Cells
  6.2.4 Brain Cells
  6.2.5 Other Human Samples
6.3 Animal Samples
6.4 Microbial Samples

7 SEGMENTATION OF GLOBAL MARKET BY WORKFLOW

7.1 Market Overview by Workflow
7.2 Single-Cell Isolation and Dispensing
  7.2.1 Fluorescence-Activated Cell Sorting (FACS)
  7.2.2 Microfluidics
  7.2.3 Magnetic-Activated Cell Sorting (MACS)
  7.2.4 Random Seeding
  7.2.5 Manual Cell Picking
  7.2.6 Laser Capture Microdissection
  7.2.7 Other Technologies of Single-Cell Isolation and Dispensing
7.3 Single-Cell Analysis
  7.3.1 Polymerase Chain Reaction
  7.3.2 Next-Generation Sequencing
  7.3.3 Mass Cytometry
  7.3.4 Mass Spectrometry
  7.3.5 Other Technologies of Single-Cell Analysis

8 SEGMENTATION OF GLOBAL MARKET BY END USER

8.1 Market Overview by End User
8.2 Research and Academic Laboratories
8.3 Biopharmaceutical and Biotech Companies
8.4 Contract Research Organizations (CROs)
8.5 Other End Users

9 SEGMENTATION OF GLOBAL MARKET BY REGION

9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
  9.2.1 Overview of North America Market
  9.2.2 U.S.
  9.2.3 Canada
  9.2.4 Mexico
9.3 European Market 2021-2031 by Country
  9.3.1 Overview of European Market
  9.3.2 Germany
  9.3.3 U.K.
  9.3.4 France
  9.3.5 Spain
  9.3.6 Italy
  9.3.7 Netherlands
  9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
  9.4.1 Overview of Asia-Pacific Market
  9.4.2 Japan
  9.4.3 China
  9.4.4 Australia
  9.4.5 India
  9.4.6 South Korea
  9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
  9.6.1 UAE
  9.6.2 Saudi Arabia
  9.6.3 South Africa
  9.6.4 Other National Markets

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles

10X GENOMICS, INC.

1CELLBIO, INC.

Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
RELATED REPORTS

LIST OF TABLES:

Table 1. Snapshot of Global Single Cell Multiomics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Comparison of Rare Disease in Different Countries
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in Global Single Cell Multiomics Market
Table 7. Global Single Cell Multiomics Market by Product Type, 2021-2031, $ mn
Table 8. Global Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 9. Global Single Cell Multiomics Market by Application, 2021-2031, $ mn
Table 10. Global Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn
Table 11. Global Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn
Table 12. Global Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn
Table 13. Global Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 14. Global Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn
Table 15. Global Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn
Table 16. Global Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 17. Global Single Cell Multiomics Market by Region, 2021-2031, $ mn
Table 18. Leading National Single Cell Multiomics Market, 2021 and 2031, $ mn
Table 19. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn
Table 20. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 21. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 22. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 23. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 24. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 25. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 26. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 27. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 28. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 29. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn
Table 30. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 31. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 32. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 33. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 34. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 35. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 36. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 37. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 38. France Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 39. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 40. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 41. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 42. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 43. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 44. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 45. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 46. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 47. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 48. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 49. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn
Table 50. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 51. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 52. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 53. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 54. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 55. China Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 56. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 57. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 58. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 59. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 60. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 61. India Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 62. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 63. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 64. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 65. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 66. South America Single Cell Multiomics Market by Country, 2021-2031, $ mn
Table 67. Argentina Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 68. Argentina Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 69. Argentina Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 70. Brazil Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 71. Brazil Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 72. Brazil Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 73. Chile Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 74. Chile Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 75. Chile Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 76. MEA Single Cell Multiomics Market by Country, 2021-2031, $ mn
Table 77. UAE Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 78. UAE Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 79. UAE Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 80. Saudi Arabia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 81. Saudi Arabia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 82. Saudi Arabia Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 83. South Africa Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 84. South Africa Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 85. South Africa Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 86. Breakdown of World Market by Key Vendor, 2020, %
Table 87. 10x Genomics, Inc.: Company Snapshot
Table 88. 10x Genomics, Inc.: Business Segmentation
Table 89. 10x Genomics, Inc.: Product Portfolio

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Single Cell Multiomics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Single Cell Multiomics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Single Cell Multiomics Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Single Cell Multiomics Market
Figure 14. Breakdown of Global Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue
Figure 15. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)
Figure 16. Global Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn
Figure 17. Global Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn
Figure 18. Global Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn
Figure 19. Breakdown of Global Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue
Figure 20. Global Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)
Figure 21. Global Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn
Figure 22. Global Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn
Figure 23. Global Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn
Figure 24. Global Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn
Figure 25. Breakdown of Global Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue
Figure 26. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 27. Global Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn
Figure 28. Global Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn
Figure 29. Global Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn
Figure 30. Global Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn
Figure 31. Global Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn
Figure 32. Global Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn
Figure 33. Global Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn
Figure 34. Global Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn
Figure 35. Global Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn
Figure 36. Breakdown of Global Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue
Figure 37. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)
Figure 38. Global Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn
Figure 39. Global Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn
Figure 40. Global Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn
Figure 41. Global Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn
Figure 42. Global Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn
Figure 43. Global Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn
Figure 44. Global Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn
Figure 45. Global Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn
Figure 46. Breakdown of Global Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue
Figure 47. Global Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)
Figure 48. Global Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn
Figure 49. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn
Figure 50. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn
Figure 51. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn
Figure 52. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn
Figure 53. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn
Figure 54. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn
Figure 55. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn
Figure 56. Global Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn
Figure 57. Global Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn
Figure 58. Global Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn
Figure 59. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn
Figure 60. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn
Figure 61. Global Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn
Figure 62. Breakdown of Global Single Cell Multiomics Market by End User, 2021-2031, % of Revenue
Figure 63. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 64. Global Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn
Figure 65. Global Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn
Figure 66. Global Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 67. Global Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn
Figure 68. Global Market Snapshot by Region
Figure 69. Geographic Spread of Worldwide Single Cell Multiomics Market, 2021-2031, % of Sales Revenue
Figure 70. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 71. North American Single Cell Multiomics Market, 2021-2031, $ mn
Figure 72. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue
Figure 73. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 74. U.S. Single Cell Multiomics Market, 2021-2031, $ mn
Figure 75. Canada Single Cell Multiomics Market, 2021-2031, $ mn
Figure 76. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn
Figure 77. European Single Cell Multiomics Market, 2021-2031, $ mn
Figure 78. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue
Figure 79. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 80. Single Cell Multiomics Market in Germany, 2021-2031, $ mn
Figure 81. Single Cell Multiomics Market in U.K., 2021-2031, $ mn
Figure 82. Single Cell Multiomics Market in France, 2021-2031, $ mn
Figure 83. Single Cell Multiomics Market in Spain, 2021-2031, $ mn
Figure 84. Single Cell Multiomics Market in Italy, 2021-2031, $ mn
Figure 85. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn
Figure 86. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn
Figure 87. Asia-Pacific Single Cell Multiomics Market, 2021-2031, $ mn
Figure 88. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue
Figure 89. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 90. Single Cell Multiomics Market in Japan, 2021-2031, $ mn
Figure 91. Single Cell Multiomics Market in China, 2021-2031, $ mn
Figure 92. Single Cell Multiomics Market in Australia, 2021-2031, $ mn
Figure 93. Single Cell Multiomics Market in India, 2021-2031, $ mn
Figure 94. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn
Figure 95. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn
Figure 96. South America Single Cell Multiomics Market, 2021-2031, $ mn
Figure 97. Breakdown of South America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue
Figure 98. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 99. Single Cell Multiomics Market in Argentina, 2021-2031, $ mn
Figure 100. Single Cell Multiomics Market in Brazil, 2021-2031, $ mn
Figure 101. Single Cell Multiomics Market in Chile, 2021-2031, $ mn
Figure 102. Single Cell Multiomics Market in Rest of South America, 2021-2031, $ mn
Figure 103. Single Cell Multiomics Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 104. Breakdown of MEA Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue
Figure 105. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 106. Single Cell Multiomics Market in UAE, 2021-2031, $ mn
Figure 107. Single Cell Multiomics Market in Saudi Arabia, 2021-2031, $ mn
Figure 108. Single Cell Multiomics Market in South Africa, 2021-2031, $ mn
Figure 109. Growth Stage of Global Single Cell Multiomics Industry over the Forecast Period


More Publications